GXI

GX International (GXI) is a prominent Filipino-owned pharmaceutical company dedicated to providing high-quality, affordable medicinal options to the Philippine market. Founded in 1991, the company focuses on therapeutic areas with high morbidity and mortality rates, including cardiovascular, metabolic, respiratory, and infectious diseases. GXI operates by sourcing raw materials from reputable global suppliers and utilizing GMP-certified national toll manufacturers to produce a wide range of branded generic medications. The company is well-regarded for its patient-centered approach and has received multiple awards for business excellence and consumer choice in the Philippines.